CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.

 

Begin main content

Human Leukocyte Antigen B27 for the Detection of Spondyloarthropathy

Last updated:
Project Number: RB1546-000
Product Line: Rapid Response
Research Type: Other Diagnostics
Report Type: Summary of Abstracts
Result type: Report

Question

  1. What is the diagnostic accuracy of human leukocyte antigen B27 testing for the detection of spondyloarthropathy in patients with low back pain and no other symptoms?
  2. What is the clinical effectiveness of human leukocyte antigen B27 testing for the detection of spondyloarthropathy in patients with low back pain and no other symptoms?
  3. What are the evidence-based guidelines for human leukocyte antigen B27 testing for the detection of spondyloarthropathy in patients with low back pain and no other symptoms?

Key Message

No evidence was identified regarding the diagnostic accuracy of human leukocyte antigen B27 testing for the detection of spondyloarthropathy in patients with low back pain and no other symptoms. No evidence was identified regarding the clinical effectiveness of human leukocyte antigen B27 testing for the detection of spondyloarthropathy in patients with low back pain and no other symptoms. No evidence-based guidelines were identified regarding human leukocyte antigen B27 testing for the detection of spondyloarthropathy in patients with low back pain and no other symptoms.